| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1038300056 |
| P356 | DOI | 10.1007/S11011-008-9118-1 |
| P698 | PubMed publication ID | 19085093 |
| P5875 | ResearchGate publication ID | 23665862 |
| P50 | author | Mario Maj | Q17306224 |
| Michael Maes | Q30504745 | ||
| Giulia Perini | Q56754406 | ||
| Marta Kubera | Q58737559 | ||
| P2093 | author name string | Jens Noraberg | |
| Bernard Lerer | |||
| Petr Bob | |||
| Joe Hibbeln | |||
| Raz Yirmyia | |||
| Stefan Brene | |||
| P2860 | cites work | Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients | Q74349181 |
| Brain interleukin-1 is involved in blood interleukin-6 response to immobilization stress in rats | Q74421978 | ||
| Novel approaches to the treatment of depression by modulating the hypothalamic - pituitary - adrenal axis | Q78440744 | ||
| Regulation of life-long neurogenesis in the decapod crustacean brain | Q80222660 | ||
| Mania associated with interferon | Q80314709 | ||
| T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients | Q81299305 | ||
| Neurotrophin levels and behaviour in BALB/c mice: impact of intermittent exposure to individual housing and wheel running | Q81605607 | ||
| Depression and long chain n-3 fatty acids in adipose tissue in adults from Crete | Q82498347 | ||
| Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration | Q21092366 | ||
| Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration | Q24614960 | ||
| The in vitro immunosuppressive effects of moclobemide in healthy volunteers | Q28141553 | ||
| Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment | Q28211825 | ||
| TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition | Q28235171 | ||
| Quinolinic acid is a potent lipid peroxidant in rat brain homogenates | Q28253979 | ||
| Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease | Q28317131 | ||
| Role of microglia in inflammation-mediated degeneration of dopaminergic neurons: neuroprotective effect of interleukin 10 | Q28564397 | ||
| Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus | Q29615348 | ||
| Oxidative stress and neurodegeneration: where are we now? | Q29617324 | ||
| More hippocampal neurons in adult mice living in an enriched environment | Q29617733 | ||
| Inflammatory Blockade Restores Adult Hippocampal Neurogenesis | Q29619037 | ||
| Inflammation is detrimental for neurogenesis in adult brain | Q29619040 | ||
| Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus | Q29619400 | ||
| An update on regional brain volume differences associated with mood disorders | Q31036543 | ||
| The effects of stress on memory and the hippocampus throughout the life cycle: implications for childhood development and aging. | Q31935368 | ||
| The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials | Q33311120 | ||
| Major depression and activation of the inflammatory response system | Q33708105 | ||
| Cytokines, "depression due to a general medical condition," and antidepressant drugs | Q33708167 | ||
| Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. | Q33730708 | ||
| Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects | Q33855426 | ||
| Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. | Q33939777 | ||
| Transduction of psychosocial stress into the neurobiology of recurrent affective disorder | Q33969745 | ||
| A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids | Q34005609 | ||
| Cellular changes in the postmortem hippocampus in major depression | Q34090433 | ||
| Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment | Q34198749 | ||
| Depression: a case of neuronal life and death? | Q34335476 | ||
| Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression | Q60730988 | ||
| Decreased serum dipeptidyl peptidase IV activity in major depression | Q68321328 | ||
| Immune disturbances during major depression: upregulated expression of interleukin-2 receptors | Q68403150 | ||
| Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells | Q71703865 | ||
| Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression | Q72674139 | ||
| Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression? | Q72824707 | ||
| Cytokine-induced intestinal epithelial hyperpermeability: role of nitric oxide | Q73148751 | ||
| Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells | Q73869333 | ||
| Fatty acids, cytokines, and major depression | Q74349174 | ||
| Antagonism of glucocorticoid receptor transactivity and cell growth inhibition by transforming growth factor-beta through AP-1-mediated transcriptional repression | Q44178907 | ||
| The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. | Q44195038 | ||
| Housing conditions modulate escitalopram effects on antidepressive-like behaviour and brain neurochemistry | Q44453534 | ||
| IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice | Q44457678 | ||
| The cortisol responses to 5-hydroxytryptophan, orally, in depressive inpatients | Q44480553 | ||
| Neurotoxic effect induced by quinolinic acid in dissociated cell culture of mouse hippocampus | Q44519054 | ||
| Propagation of major depressive disorder: relationship between first episode symptoms and recurrence | Q44662608 | ||
| Neuroscience. Microglia: the enemy within? | Q44681258 | ||
| Lower high-density lipoprotein cholesterol and increased omega-6 polyunsaturated fatty acids in first-degree relatives of bipolar patients | Q44769160 | ||
| Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy | Q44801155 | ||
| Dietary ethyl-eicosapentaenoic acid but not soybean oil reverses central interleukin-1-induced changes in behavior, corticosterone and immune response in rats | Q44941884 | ||
| IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity | Q45115322 | ||
| Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats | Q45239646 | ||
| Quinolinic acid-induced lesions of the rat striatum: quantitative autoradiographic binding assessment. | Q45295637 | ||
| Differential vulnerability of central neurons of the rat to quinolinic acid | Q45304810 | ||
| Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus | Q45730010 | ||
| Interferon gamma induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process | Q46485035 | ||
| Serological observations in patients suffering from acute manic episodes | Q46511445 | ||
| Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation | Q46531302 | ||
| Glucocorticoid enhances the neurotoxic actions of quinolinic acid in the striatum in a cell-specific manner | Q46536606 | ||
| Gender differences in depression: findings from the STAR*D study. | Q46570134 | ||
| Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway | Q46605002 | ||
| Effect of long-lasting serotonin depletion on environmental enrichment-induced neurogenesis in adult rat hippocampus and spatial learning | Q46672783 | ||
| Phosphorylation of Neurogenin2 specifies the migration properties and the dendritic morphology of pyramidal neurons in the neocortex. | Q46734175 | ||
| Cutaneous glucocorticoid receptor sensitivity and pro-inflammatory cytokine levels in antidepressant-resistant depression. | Q46779294 | ||
| Neurodegenerative actions of interleukin-1 in the rat brain are mediated through increases in seizure activity | Q46854140 | ||
| The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation | Q46862597 | ||
| Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder | Q46920762 | ||
| Increased serum levels of 8-hydroxy-2'-deoxyguanosine in clinical depression | Q46921439 | ||
| Docosahexaenoic acid promotes neurogenesis in vitro and in vivo | Q46983256 | ||
| Psychomotor retardation, anorexia, weight loss, sleep disturbances, and loss of energy: psychopathological correlates of hyperhaptoglobinemia during major depression | Q47392531 | ||
| Fish consumption and major depression | Q47757469 | ||
| The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. | Q48002329 | ||
| Anxiety and increased 5-HT1A receptor response in NCAM null mutant mice | Q48141177 | ||
| Effects of lithium and valproate on serum and hippocampal neurotrophin-3 levels in an animal model of mania | Q48162446 | ||
| Interferon-alpha effects are exaggerated when administered on a psychosocial stressor backdrop: cytokine, corticosterone and brain monoamine variations | Q48207495 | ||
| The developmental expression of fluorescent proteins in organotypic hippocampal slice cultures from transgenic mice and its use in the determination of excitotoxic neurodegeneration. | Q48215868 | ||
| Quinolinate mimics neurotoxic actions of N-methyl-D-aspartate in rat cerebellar slices | Q48219670 | ||
| Interleukin-1beta but not tumor necrosis factor-alpha potentiates neuronal damage by quinolinic acid: protection by an adenosine A2A receptor antagonist | Q48270914 | ||
| Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol | Q48289993 | ||
| Tryptophan breakdown pathway in bipolar mania | Q48290210 | ||
| The neurotoxic actions of quinolinic acid in the central nervous system | Q48374376 | ||
| Omega-3 fatty acids on the forced-swimming test | Q48385318 | ||
| Phospholipid metabolism and depression: the possible roles of phospholipase A2 and coenzyme A-independent transacylase | Q48458508 | ||
| Omega-3 fatty acid ethyl-eicosapentaenoate attenuates IL-1beta-induced changes in dopamine and metabolites in the shell of the nucleus accumbens: involved with PLA2 activity and corticosterone secretion | Q48489400 | ||
| Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex | Q48499710 | ||
| Maternal dietary (n-3) fatty acid deficiency alters neurogenesis in the embryonic rat brain | Q48538691 | ||
| Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors | Q48541992 | ||
| The slice overlay assay: a versatile tool to study the influence of extracellular signals on neuronal development | Q48582810 | ||
| Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha. | Q48601042 | ||
| BDNF in schizophrenia, depression and corresponding animal models | Q34385320 | ||
| Endotoxin produces a depressive-like episode in rats. | Q34386691 | ||
| The antidepressant effect of running is associated with increased hippocampal cell proliferation | Q34403181 | ||
| Depresssion--emerging insights from neurobiology | Q34446950 | ||
| The effects of psychological stress on leukocyte subset distribution in humans: evidence of immune activation | Q34488170 | ||
| The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine | Q34496400 | ||
| Pathophysiology of depression: the concept of synaptic plasticity | Q34548351 | ||
| Oxidative stress in neurodegeneration: mechanisms and therapeutic perspectives | Q34564430 | ||
| Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation | Q34571497 | ||
| Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression | Q34614619 | ||
| The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis | Q34624993 | ||
| Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats | Q34647175 | ||
| Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. | Q34655648 | ||
| Not in the mind but in the cell: increased production of cyclo-oxygenase-2 and inducible NO synthase in chronic fatigue syndrome. | Q34662233 | ||
| Not in the mind of neurasthenic lazybones but in the cell nucleus: patients with chronic fatigue syndrome have increased production of nuclear factor kappa beta. | Q34662238 | ||
| Bipolar II disorder : epidemiology, diagnosis and management | Q34662637 | ||
| Is it time to reassess the BDNF hypothesis of depression? | Q34663655 | ||
| Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS a | Q34722543 | ||
| Mode of action of mood stabilizers: is the arachidonic acid cascade a common target? | Q34762525 | ||
| Further evidence for the depressive effects of cytokines: anhedonia and neurochemical changes | Q34980850 | ||
| Effects of antidepressants on the production of cytokines | Q35017013 | ||
| Oxidative stress in neurodegenerative diseases: therapeutic implications for superoxide dismutase mimetics | Q35116171 | ||
| Neurokynurenines (NEKY) as common neurochemical links of stress and anxiety | Q35810557 | ||
| Omega-3 fatty acids upregulate adult neurogenesis. | Q35842841 | ||
| Is impaired neurogenesis relevant to the affective symptoms of depression? | Q35844562 | ||
| Neurogenesis and depression: etiology or epiphenomenon? | Q35844569 | ||
| Sickness behavior as a new target for drug development | Q35899947 | ||
| Alterations of neuroplasticity in depression: the hippocampus and beyond. | Q35953971 | ||
| Stress, cognitive impairment and cell adhesion molecules | Q35954292 | ||
| Cytokines and major depression | Q36031971 | ||
| Cytokines as a precipitant of depressive illness: animal and human studies | Q36074596 | ||
| The Flinders Sensitive Line rat: a selectively bred putative animal model of depression | Q36145095 | ||
| Organotypic hippocampal slice cultures for studies of brain damage, neuroprotection and neurorepair | Q36230555 | ||
| Brain response to injury and neurodegeneration: endogenous neuroprotective signaling | Q36265300 | ||
| Nitric oxide, S-nitrosylation and neurodegeneration | Q36271167 | ||
| IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress | Q36393030 | ||
| The role of oxidative stress in the dysregulation of gene expression and protein metabolism in neurodegenerative disease | Q36399776 | ||
| The fibroblast growth factor system and mood disorders. | Q36456340 | ||
| Nitric oxide, cell bioenergetics and neurodegeneration. | Q36521937 | ||
| Mitochondrial dysfunction, oxidative stress and neurodegeneration. | Q36599784 | ||
| Is there a continuity between bipolar and depressive disorders? | Q36710703 | ||
| Multiple genes and factors associated with bipolar disorder converge on growth factor and stress activated kinase pathways controlling translation initiation: implications for oligodendrocyte viability. | Q36713630 | ||
| A model for the involvement of neural cell adhesion molecules in stress-related mood disorders | Q36780510 | ||
| Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods | Q36795521 | ||
| Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena | Q36842982 | ||
| The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior | Q36925139 | ||
| Interleukin-2-induced changes in behavioural, neurotransmitter, and immunological parameters in the olfactory bulbectomized rat. | Q38291798 | ||
| Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode | Q39270744 | ||
| Cost of depression in Europe | Q40284204 | ||
| A review on the acute phase response in major depression | Q40385174 | ||
| The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression | Q40385577 | ||
| Evidence for an immune response in major depression: a review and hypothesis | Q40501767 | ||
| Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response | Q40531797 | ||
| Sex-related differences in the relationships between self-rated depression and biological markers | Q41269807 | ||
| Exposure to acute stress induces brain interleukin-1beta protein in the rat. | Q41712832 | ||
| Behavioral effects of infection with IL-6 adenovector | Q43547838 | ||
| Paroxetine for the prevention of depression induced by high-dose interferon alfa | Q43556890 | ||
| Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. | Q43562225 | ||
| Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1beta in the rat. | Q43567783 | ||
| Quinolinic acid-iron(ii) complexes: slow autoxidation, but enhanced hydroxyl radical production in the Fenton reaction | Q43621641 | ||
| Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis | Q43670227 | ||
| Effects of pregnancy and delivery on the availability of plasma tryptophan to the brain: relationships to delivery-induced immune activation and early post-partum anxiety and depression | Q43679609 | ||
| Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system | Q43859445 | ||
| Cortisol, serotonin and depression: all stressed out? | Q43873953 | ||
| Mood, cognition and EEG changes during interferon alpha (alpha-IFN) treatment for chronic hepatitis C. | Q43899923 | ||
| Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis | Q43901012 | ||
| Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation | Q44100268 | ||
| Effects of subchronic treatment with valproate on L-5-HTP-induced cortisol responses in mania: evidence for increased central serotonergic neurotransmission | Q48660071 | ||
| Paradoxical effects of learning the Morris water maze on adult hippocampal neurogenesis in mice may be explained by a combination of stress and physical activity | Q48673583 | ||
| Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation | Q48757518 | ||
| Reduced preference for sucrose in autoimmune mice: a possible role of interleukin-6. | Q48770967 | ||
| Changes in hippocampal IL-15, related cytokines, and neurogenesis in IL-2 deficient mice | Q48929923 | ||
| Lower serum L-tryptophan availability in depression as a marker of a more generalized disorder in protein metabolism | Q48931699 | ||
| Tumor necrosis factor-alpha and interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes | Q49049474 | ||
| Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. | Q50705251 | ||
| Cytokines and cholinergic signals co-modulate surgical stress-induced changes in mood and memory. | Q50883653 | ||
| Conditional ablation of the neural cell adhesion molecule reduces precision of spatial learning, long-term potentiation, and depression in the CA1 subfield of mouse hippocampus. | Q51029078 | ||
| Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. | Q51059710 | ||
| Social isolation increases number of newly proliferated cells in hippocampus in female flinders sensitive line rats. | Q51736775 | ||
| In vitro immunoregulatory effects of lithium in healthy volunteers. | Q51984033 | ||
| Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. | Q51984734 | ||
| Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance. | Q51985448 | ||
| Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. | Q51996803 | ||
| Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. | Q51999219 | ||
| Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. | Q52017804 | ||
| Developmental regulation of BDNF and NT-3 expression by quinolinic acid in the striatum and its main connections. | Q52165694 | ||
| Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. | Q53573170 | ||
| Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis. | Q53784738 | ||
| Leukocyte subsets in treatment-resistant major depression. | Q54051056 | ||
| An IgM-mediated immune response directed against nitro-bovine serum albumin (nitro-BSA) in chronic fatigue syndrome (CFS) and major depression: evidence that nitrosative stress is another factor underpinning the comorbidity between major depression a | Q56767133 | ||
| The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression | Q56767137 | ||
| Lowered Serum Dipeptidyl Peptidase IV Activity is Associated with Depressive Symptoms and Cytokine Production in Cancer Patients Receiving Interleukin-2-Based Immunotherapy | Q56767259 | ||
| Prolonged desipramine treatment increases the production of interleukin-10, an anti-inflammatory cytokine, in C57BL/6 mice subjected to the chronic mild stress model of depression | Q56767269 | ||
| The inflammatory response following delivery is amplified in women who previously suffered from major depression, suggesting that major depression is accompanied by a sensitization of the inflammatory response system | Q56767280 | ||
| In humans, serum polyunsaturated fatty acid levels predict the response of proinflammatory cytokines to psychologic stress | Q56767303 | ||
| Negative Immunoregulatory Effects of Antidepressants Inhibition of Interferon-γ and Stimulation of Interleukin-10 Secretion | Q56767354 | ||
| Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs | Q56767386 | ||
| Fatty acid composition in major depression: decreased ω3 fractions in cholesteryl esters and increased C20:4ω6C20:5ω3 ratio in cholesteryl esters and phospholipids | Q56767442 | ||
| Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers | Q56767487 | ||
| The monocyte-T-lymphocyte hypothesis of major depression | Q56767511 | ||
| Relationships between increased haptoglobin plasma levels and activation of cell-mediated immunity in depression | Q56767551 | ||
| Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression | Q56767554 | ||
| Effect of chronic treatment with imipramine on interleukin 1 and interleukin 2 production by splenocytes obtained from rats subjected to a chronic mild stress model of depression | Q57221581 | ||
| Interleukin-1β Released by gp120 Drives Neural Death through Tyrosine Phosphorylation and Trafficking of NMDA Receptors | Q57372490 | ||
| Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: A possible role for lithium antioxidant effects | Q60492133 | ||
| Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy | Q60727624 | ||
| P433 | issue | 1 | |
| P921 | main subject | neurodegeneration | Q1755122 |
| P304 | page(s) | 27-53 | |
| P577 | publication date | 2008-12-16 | |
| P1433 | published in | Metabolic Brain Disease | Q15764352 |
| P1476 | title | The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression | |
| P478 | volume | 24 |
| Q33361260 | "Sundowning" as a biological phenomenon: current understandings and future directions: an update |
| Q37677049 | 1-Methyl-1,2,3,4-tetrahydroisoquinoline, an endogenous Neuroprotectant and MAO inhibitor with antidepressant-like properties in the rat. |
| Q38965286 | A Slice of the Suicidal Brain: What Have Postmortem Molecular Studies Taught Us? |
| Q34631232 | A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase |
| Q39393721 | A case of anorexia nervosa with comorbid Crohn's disease: beneficial effects of anti-TNF-α therapy? |
| Q26778489 | A meta-analysis of lipid peroxidation markers in major depression |
| Q36385728 | A pilot genome wide association and gene expression array study of suicide with and without major depression |
| Q35988667 | A potential role for the acid-sensing T cell death associated gene-8 (TDAG8) receptor in depression-like behavior. |
| Q93077579 | A potential role for the gut microbiome in substance use disorders |
| Q33738683 | ASMT gene expression correlates with cognitive impairment in patients with recurrent depressive disorder |
| Q37358977 | Accelerated aging in major depression: the role of nitro-oxidative stress |
| Q29994732 | Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors |
| Q46370895 | Acute and chronic treatment with quetiapine induces antidepressant-like behavior and exerts antioxidant effects in the rat brain. |
| Q92356780 | Acute exposure to low-level light at night is sufficient to induce neurological changes and depressive-like behavior |
| Q47657381 | Add-on Treatment with Curcumin Has Antidepressive Effects in Thai Patients with Major Depression: Results of a Randomized Double-Blind Placebo-Controlled Study |
| Q52603659 | Aggression, Social Stress, and the Immune System in Humans and Animal Models. |
| Q38969497 | Agmatine induces Nrf2 and protects against corticosterone effects in hippocampal neuronal cell line |
| Q38875865 | Agmatine, by Improving Neuroplasticity Markers and Inducing Nrf2, Prevents Corticosterone-Induced Depressive-Like Behavior in Mice |
| Q47769833 | Altered B Cell Homeostasis in Patients with Major Depressive Disorder and Normalization of CD5 Surface Expression on Regulatory B Cells in Treatment Responders |
| Q47866071 | Altered serum levels of TNF-α, IL-6, and IL-18 in depressive disorder patients. |
| Q34414219 | An investigation of the antidepressant action of xiaoyaosan in rats using ultra performance liquid chromatography-mass spectrometry combined with metabonomics |
| Q36223676 | Analysis of region-specific changes in gene expression upon treatment with citalopram and desipramine reveals temporal dynamics in response to antidepressant drugs at the transcriptome level |
| Q46627623 | Anti-inflammatory properties of tianeptine on lipopolysaccharide-induced changes in microglial cells involve toll-like receptor-related pathways |
| Q33663230 | Antidepressant effects of resveratrol in an animal model of depression |
| Q92376687 | Antidepressant-Like Effect and Mechanism of Action of Honokiol on the Mouse Lipopolysaccharide (LPS) Depression Model |
| Q38757053 | Antidepressants Accumulate in Lipid Rafts Independent of Monoamine Transporters to Modulate Redistribution of the G Protein, Gαs |
| Q48958164 | Association between C-281A and val66met functional polymorphisms of BDNF gene and risk of recurrent major depressive disorder in Polish population |
| Q52669792 | Association between high serum carcinoembryonic antigen and clinical state of male anorexia nervosa: A case report. |
| Q36686518 | Association of Anterior Cingulate Glutathione with Sleep Apnea in Older Adults At-Risk for Dementia. |
| Q33838255 | Association of subsyndromal and depressive symptoms with inflammatory markers among different ethnic groups: the multi-ethnic study of atherosclerosis (MESA). |
| Q33990649 | Association of trauma exposure with proinflammatory activity: a transdiagnostic meta-analysis |
| Q28390187 | Astrocyte heterogeneity in the brain: from development to disease |
| Q26827833 | Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue |
| Q35592026 | Astrocytic hypertrophy in anterior cingulate white matter of depressed suicides |
| Q47697894 | Basal blood DHEA-S/cortisol levels predicts EMDR treatment response in adolescents with PTSD. |
| Q27304801 | Behavioral assessment of NIH Swiss mice acutely intoxicated with tetramethylenedisulfotetramine |
| Q34557706 | Beyond serotonin: newer antidepressants in the future |
| Q37778476 | Beyond the serotonin hypothesis: Mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders |
| Q38062564 | Biological aspects of postpartum depression |
| Q38995726 | Biological hypotheses and biomarkers of bipolar disorder |
| Q34079375 | Biological mechanisms underlying the role of physical fitness in health and resilience |
| Q35118685 | Brain interleukin-1β and the intrinsic receptor antagonist control peripheral Toll-like receptor 3-mediated suppression of spontaneous activity in rats |
| Q37310546 | Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets |
| Q50976845 | Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): objectives and design. |
| Q48971746 | CTLA-4 confers a risk of recurrent schizophrenia, major depressive disorder and bipolar disorder in the Chinese Han population |
| Q38247989 | Cardiac autonomic imbalance by social stress in rodents: understanding putative biomarkers |
| Q47854008 | Cathepsin C Aggravates Neuroinflammation Involved in Disturbances of Behaviour and Neurochemistry in Acute and Chronic Stress-Induced Murine Model of Depression |
| Q37197588 | Chelidonic acid evokes antidepressant-like effect through the up-regulation of BDNF in forced swimming test |
| Q36184301 | Chemically Bonding of Amantadine with Gardenamide A Enhances the Neuroprotective Effects against Corticosterone-Induced Insults in PC12 Cells |
| Q46020755 | Chronic administration of infliximab (TNF-α inhibitor) decreases depression and anxiety-like behaviour in rat model of chronic mild stress. |
| Q36755176 | Chronic depression as a model disease for cerebral aging |
| Q42735475 | Chronic fatigue syndrome: Harvey and Wessely's (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways |
| Q42945730 | Chronic variable stress induces oxidative stress and decreases butyrylcholinesterase activity in blood of rats. |
| Q45300839 | Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. |
| Q35722828 | Clinical research with transcranial direct current stimulation (tDCS): challenges and future directions |
| Q48131490 | Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial. |
| Q45027559 | Common polymorphisms in nitric oxide synthase (NOS) genes influence quality of aging and longevity in humans |
| Q57193576 | Comparative study of esketamine and racemic ketamine in treatment-resistant depression: Protocol for a non-inferiority clinical trial |
| Q34624634 | Coordinated messenger RNA/microRNA changes in fibroblasts of patients with major depression. |
| Q33968401 | Cytokine gene variation is associated with depressive symptom trajectories in oncology patients and family caregivers |
| Q30581961 | Cytokine gene variations associated with subsyndromal depressive symptoms in patients with breast cancer |
| Q33842988 | Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial |
| Q38820530 | DNA Damage in Major Psychiatric Diseases |
| Q35075256 | Deletion of ovarian hormones induces a sickness behavior in rats comparable to the effect of lipopolysaccharide. |
| Q37682601 | Delirium and depression: inter-relationship and clinical overlap in elderly people |
| Q35891902 | Depression and risk of developing dementia |
| Q26823313 | Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways |
| Q37727112 | Depression gets old fast: do stress and depression accelerate cell aging? |
| Q58707223 | Depression, malnutrition, and health-related quality of life among Nepali older patients |
| Q37183514 | Depression: A repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition? |
| Q50531989 | Depressive Symptom Dimensions and Their Association with Hippocampal and Entorhinal Cortex Volumes in Community Dwelling Older Adults |
| Q48279199 | Design, synthesis, and pharmacological evaluation of novel 2-(4-substituted piperazin-1-yl)1, 8 naphthyridine 3-carboxylic acids as 5-HT3 receptor antagonists for the management of depression |
| Q49846010 | Differential effects of acute versus chronic stress on ethanol sensitivity: evidence for interactions on both behavioral and neuroimmune outcomes. |
| Q58802428 | Differentially expressed genes related to major depressive disorder and antidepressant response: genome-wide gene expression analysis |
| Q33788445 | Directed evolution of a three-finger neurotoxin by using cDNA display yields antagonists as well as agonists of interleukin-6 receptor signaling |
| Q34660464 | Docosahexaenoic Acid Suppresses Neuroinflammatory Responses and Induces Heme Oxygenase-1 Expression in BV-2 Microglia: Implications of Antidepressant Effects for Omega-3 Fatty Acids |
| Q38901511 | Does Diet Matter? The Use of Polyunsaturated Fatty Acids (PUFAs) and Other Dietary Supplements in Inflammation-Associated Depression |
| Q36944840 | Duality of Antidepressants and Neuroprotectants |
| Q58705534 | Dvl3 polymorphism interacts with life events and pro-inflammatory cytokines to influence major depressive disorder susceptibility |
| Q48385750 | Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis. |
| Q47341920 | Early-Life Social Isolation-Induced Depressive-Like Behavior in Rats Results in Microglial Activation and Neuronal Histone Methylation that Are Mitigated by Minocycline |
| Q43191771 | Effect of co-administration of fluoxetine and amantadine on immunoendocrine parameters in rats subjected to a forced swimming test |
| Q43649709 | Effect of low doses of progesterone in the expression of the GABA(A) receptor α4 subunit and procaspase-3 in the hypothalamus of female rats |
| Q35903305 | Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection |
| Q35812335 | Effects of Antidepressants on DSP4/CPT-Induced DNA Damage Response in Neuroblastoma SH-SY5Y Cells |
| Q55177615 | Elevated serum levels of malondialdehyde and cortisol are associated with major depressive disorder: A case-control study. |
| Q34726433 | Epigenetic and inflammatory marker profiles associated with depression in a community-based epidemiologic sample. |
| Q40630941 | Evaluating [11C]PBR28 PET for Monitoring Gut and Brain Inflammation in a Rat Model of Chemically Induced Colitis. |
| Q53836933 | Exploring the association between whole blood Omega-3 Index, DHA, EPA, DHA, AA and n-6 DPA, and depression and self-esteem in adolescents of lower general secondary education. |
| Q60910510 | Faecal Short Chain Fatty Acids Profile is Changed in Polish Depressive Women |
| Q38721869 | Ferulic acid suppresses expression of tryptophan metabolic key enzyme indoleamine 2, 3-dioxygenase via NFκB and p38 MAPK in lipopolysaccharide-stimulated microglial cells |
| Q47280324 | Fish oil and depression: The skinny on fats |
| Q52360936 | Focus on fatty acids in the neurometabolic pathophysiology of psychiatric disorders. |
| Q34309215 | Four research findings that will change what we think about perinatal depression |
| Q36889750 | Fractalkine Attenuates Microglial Cell Activation Induced by Prenatal Stress |
| Q47695435 | Gap junction channels as potential targets for the treatment of major depressive disorder |
| Q39015204 | Gastrointestinal comorbidities which complicate the treatment of anorexia nervosa |
| Q54280525 | Gene expression analysis reveals schizophrenia-associated dysregulation of immune pathways in peripheral blood mononuclear cells. |
| Q37109491 | Genetic overlap between type 2 diabetes and major depressive disorder identified by bioinformatics analysis |
| Q41994130 | Gestational diabetes exacerbates maternal immune activation effects in the developing brain. |
| Q42673840 | Glucocorticoid receptor dimerization is required for proper recovery of LPS-induced inflammation, sickness behavior and metabolism in mice |
| Q27024383 | Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction |
| Q36442019 | Glucocorticoids, cytokines and brain abnormalities in depression |
| Q56672658 | Glyphosate’s Suppression of Cytochrome P450 Enzymes and Amino Acid Biosynthesis by the Gut Microbiome: Pathways to Modern Diseases |
| Q39438471 | High level interleukin-6 in the medium of human pancreatic cancer cell culture suppresses production of neurotransmitters by PC12 cell line. |
| Q40184390 | High serum total cholesterol is associated with suicide mortality in Japanese women |
| Q90479791 | IDO and Kynurenine Metabolites in Peripheral and CNS Disorders |
| Q38315020 | Immune mechanisms linked to depression via oxidative stress and neuroprogression |
| Q36908139 | Immune system inflammation in cocaine dependent individuals: implications for medications development |
| Q51761592 | Impact of Aging on the Auditory System and Related Cognitive Functions: A Narrative Review. |
| Q52654781 | In major affective disorders, early life trauma predict increased nitro-oxidative stress, lipid peroxidation and protein oxidation and recurrence of major affective disorders, suicidal behaviors and a lowered quality of life. |
| Q48475221 | Increased frequency of cluster of differentiation 14 (CD14+) monocytes expressing interleukin 1 beta (IL-1β) in Alzheimer's disease patients and intermediate levels in late-onset depression patients. |
| Q48119273 | Increased neuroplasticity may protect against cardiovascular disease |
| Q92188579 | Indigenous Subarctic Food Systems in Transition: Amino Acid Composition (Including Tryptophan) in Wild-Harvested and Processed Meats |
| Q92639608 | Individual differences in inflammatory and oxidative mechanisms of stress-related mood disorders |
| Q38199487 | Individual differences in the neurobiology of social stress: implications for depression-cardiovascular disease comorbidity |
| Q39098530 | Inflammation and depression: a causal or coincidental link to the pathophysiology? |
| Q35233681 | Inflammation and neuronal plasticity: a link between childhood trauma and depression pathogenesis. |
| Q60950197 | Inflammatory Profiles in Depressed Adolescents Treated with Fluoxetine: An 8-Week Follow-up Open Study |
| Q48852269 | Inflammatory biomarkers in depression: an opportunity for novel therapeutic interventions |
| Q43191760 | Inhibitory effects of amantadine on the production of pro-inflammatory cytokines by stimulated in vitro human blood |
| Q26775316 | Innate and adaptive immunity in the development of depression: An update on current knowledge and technological advances |
| Q39445647 | Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis |
| Q34159724 | Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis. |
| Q36832872 | Interplay between pro-inflammatory cytokines and growth factors in depressive illnesses |
| Q47773748 | Intestinal microbiome-gut-brain axis and irritable bowel syndrome. |
| Q60473680 | Ionic Glutamate Modulators in Depression (Zinc, Magnesium) |
| Q34499830 | Kinin B1 receptors mediate depression-like behavior response in stressed mice treated with systemic E. coli lipopolysaccharide. |
| Q28741691 | Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress--preliminary findings |
| Q92069767 | Life style, Perfusion deficits and Co-morbidities Precipitate Inflammation and Cerebrovascular Disorders in Aged Subjects |
| Q57157635 | Linking unfolded protein response to inflammation and depression: potential pathologic and therapeutic implications |
| Q34775703 | Lipid peroxidation and depressed mood in community-dwelling older men and women |
| Q37016842 | Long-Term Use of Selective Serotonin Reuptake Inhibitors and Risk of Glaucoma in Depression Patients |
| Q47663680 | Low Vs. High Alcohol: Central Benefits Vs. Detriments. |
| Q36211387 | Lower Urinary Tract Symptoms, Depression, Anxiety and Systemic Inflammatory Factors in Men: A Population-Based Cohort Study |
| Q52318289 | Major Differences in Neurooxidative and Neuronitrosative Stress Pathways Between Major Depressive Disorder and Types I and II Bipolar Disorder. |
| Q38623015 | Mammary Tumors Induce Central Pro-inflammatory Cytokine Expression, but Not Behavioral Deficits in Balb/C Mice. |
| Q37863685 | Marine omega-3 fatty acids and mood disorders--linking the sea and the soul. 'Food for Thought' I. |
| Q57469273 | Medial Forebrain Bundle Deep Brain Stimulation Reverses Anhedonic-Like Behavior in a Chronic Model of Depression: Importance of BDNF and Inflammatory Cytokines |
| Q44746502 | Medical comorbidity in recurrent versus first-episode depressive patients |
| Q46916643 | Metabolic and glutathione redox markers associated with brain-derived neurotrophic factor in depressed african men and women: evidence for counterregulation? |
| Q46327960 | Methylene blue and its analogues as antidepressant compounds. |
| Q41699494 | Microglia: An Interface between the Loss of Neuroplasticity and Depression |
| Q34091504 | Mifepristone prevents stress-induced apoptosis in newborn neurons and increases AMPA receptor expression in the dentate gyrus of C57/BL6 mice |
| Q34554827 | Migraine associated with gastrointestinal disorders: review of the literature and clinical implications |
| Q90263636 | Minocycline prevents the development of depression-like behavior and hippocampal inflammation in a rat model of Alzheimer's disease |
| Q22241418 | Minocycline: therapeutic potential in psychiatry |
| Q61449989 | Mitochondria, Microglia, and the Immune System-How Are They Linked in Affective Disorders? |
| Q42919834 | Moclobemide exerts anti-inflammatory effect in lipopolysaccharide-activated primary mixed glial cell culture. |
| Q37668003 | Multi-analyte profile analysis of plasma immune proteins: altered expression of peripheral immune factors is associated with neuropsychiatric symptom severity in adults with and without chronic hepatitis C virus infection. |
| Q38049302 | Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects |
| Q34340306 | N-3 (omega-3) Fatty acids in postpartum depression: implications for prevention and treatment |
| Q26849307 | N-3 (omega-3) polyunsaturated Fatty acids in the pathophysiology and treatment of depression: pre-clinical evidence |
| Q93160297 | NK cell-derived exosomes carry miR-207 and alleviate depression-like symptoms in mice |
| Q58596391 | Near-Infrared Photobiomodulation Combined with Coenzyme Q for Depression in a Mouse Model of Restraint Stress: Reduction in Oxidative Stress, Neuroinflammation, and Apoptosis |
| Q47586564 | Neurobiological parameters in quantitative prediction of treatment outcome in schizophrenic patients |
| Q92485063 | Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates |
| Q34103068 | Neuroendocrine and immune contributors to fatigue |
| Q37532906 | Neuroimmune Interface in the Comorbidity between Alcohol Use Disorder and Major Depression |
| Q35758842 | Neuroimmune endocrine effects of antidepressants |
| Q34369407 | Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. |
| Q37116106 | Neuroinflammation, neurodegeneration, and depression. |
| Q36451817 | Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis. |
| Q64972277 | Neuroprotective Effects of Anthraquinones from Rhubarb in Central Nervous System Diseases. |
| Q35991228 | Neuroprotective Role of L-NG-Nitroarginine Methyl Ester (L-NAME) against Chronic Hypobaric Hypoxia with Crowding Stress (CHC) Induced Depression-Like Behaviour |
| Q48958182 | Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: behavioral and biochemical evidences. |
| Q37978196 | New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors. |
| Q48239049 | Nipple pain during breastfeeding with or without visible trauma. |
| Q35237227 | Of sound mind and body: depression, disease, and accelerated aging |
| Q21284717 | Omega-3 fatty acids and depression: scientific evidence and biological mechanisms |
| Q37953519 | Omega-3 fatty acids and ginger in maternal health: pharmacology, efficacy, and safety |
| Q26738789 | Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches |
| Q43105430 | Oxidative stress and major depression |
| Q38189557 | Oxidative stress markers in affective disorders. |
| Q57074528 | PTSD patients show increasing cytokine levels during treatment despite reduced psychological distress |
| Q42580192 | Pain and opioid use in chronic liver disease: optimal treatment must address the mental health care needs of the patient |
| Q27000066 | Parallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerability |
| Q28384484 | Paroxetine ameliorates lipopolysaccharide-induced microglia activation via differential regulation of MAPK signaling |
| Q37831342 | Pathobiological targets of depression. |
| Q37763086 | Pathogenesis and diagnosis of hepatic encephalopathy |
| Q26749017 | Pathogenetic and Therapeutic Applications of Tumor Necrosis Factor-α (TNF-α) in Major Depressive Disorder: A Systematic Review |
| Q38230661 | Perfusion deficits, inflammation and aging precipitate depressive behaviour |
| Q47367738 | Peripheral Immune System Adaptations and Motivation for Alcohol in Non-Dependent Problem Drinkers |
| Q34660056 | Peripheral and Central Mechanisms of Stress Resilience |
| Q37176590 | Peripheral biomarkers in animal models of major depressive disorder |
| Q42511911 | Peripheral immune system suppression in early abstinent alcohol-dependent individuals: Links to stress and cue-related craving |
| Q48061279 | Piperine Augments the Protective Effect of Curcumin Against Lipopolysaccharide-Induced Neurobehavioral and Neurochemical Deficits in Mice |
| Q90585666 | Plasma and cerebrospinal fluid inflammatory cytokines in perinatal depression |
| Q36310734 | Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder |
| Q48685238 | Plasma magnesium levels and treatment outcome in depressed patients |
| Q95315172 | Plasma redox and inflammatory patterns during major depressive episodes: a cross-sectional investigation in elderly patients with mood disorders |
| Q35170354 | Prenatal stress is a vulnerability factor for altered morphology and biological activity of microglia cells |
| Q48267490 | Prodromal depression in pancreatic cancer: retrospective evaluation on ten patients |
| Q92228613 | Progesterone exerts antidepressant-like effect in a mouse model of maternal separation stress through mitigation of neuroinflammatory response and oxidative stress |
| Q33932852 | Prolonged depression-like behavior caused by immune challenge: influence of mouse strain and social environment. |
| Q43269486 | Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: results of the Virahep-C study |
| Q34942602 | Protocol and rationale-the efficacy of minocycline as an adjunctive treatment for major depressive disorder: a double blind, randomised, placebo controlled trial |
| Q39757070 | Psychosis post corona radiata and lentiform nucleus infarction |
| Q92994173 | Reduced grey matter volume in frontal and temporal areas in depression: contributions from voxel-based morphometry study |
| Q26768609 | Reelin-Related Disturbances in Depression: Implications for Translational Studies |
| Q93104581 | Relationship between the Intake of n-3 Polyunsaturated Fatty Acids and Depressive Symptoms in Elderly Japanese People: Differences According to Sex and Weight Status |
| Q38290421 | Relevance of the anti-inflammatory properties of curcumin in neurodegenerative diseases and depression. |
| Q38681297 | Rescue of IL-1β-induced reduction of human neurogenesis by omega-3 fatty acids and antidepressants |
| Q26786208 | Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression |
| Q38136672 | Research review: the role of cytokines in depression in adolescents: a systematic review |
| Q67874336 | Role of Chronic Administration of Antidepressant Drugs in the Prenatal Stress-Evoked Inflammatory Response in the Brain of Adult Offspring Rats: Involvement of the NLRP3 Inflammasome-Related Pathway. |
| Q37593869 | Role of inflammatory cytokines in depression: Focus on interleukin-1β. |
| Q33578486 | Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials |
| Q28728766 | Selective hyper-responsiveness of the interferon system in major depressive disorders and depression induced by interferon therapy |
| Q58794277 | Serum concentrations of interleukin 18 and 25-hydroxyvitamin D3 correlate with depression severity in men with psoriasis |
| Q38266209 | Shared neurobiological pathways between type 2 diabetes and depressive symptoms: a review of morphological and neurocognitive findings |
| Q90680584 | Significant Decrease in Hippocampus and Amygdala Mean Diffusivity in Treatment-Resistant Depression Patients Who Respond to Electroconvulsive Therapy |
| Q36067322 | Somatic drugs for psychiatric diseases: aspirin or simvastatin for depression? |
| Q47096228 | Stress & the gut-brain axis: Regulation by the microbiome |
| Q91921027 | Stress hypothesis overload: 131 hypotheses exploring the role of stress in tradeoffs, transitions, and health |
| Q35713356 | Stress, depression and Parkinson's disease |
| Q48281041 | Stress-Induced Alterations of Immune Profile in Animals Suffering by Tau Protein-Driven Neurodegeneration. |
| Q48371668 | Structural brain changes associated with depressive symptoms in the elderly with Alzheimer's disease |
| Q38822609 | Supervised, Vigorous Intensity Exercise Intervention for Depressed Female Smokers: A Pilot Study |
| Q37044561 | Systemic immune activation leads to neuroinflammation and sickness behavior in mice |
| Q36851815 | Systemic inflammation, depression and obstructive pulmonary function: a population-based study |
| Q38038284 | Targeting IL-1 in depression |
| Q38189135 | Targeting classical IL-6 signalling or IL-6 trans-signalling in depression? |
| Q38024740 | Targeting cyclooxygenase-2 in depression is not a viable therapeutic approach and may even aggravate the pathophysiology underpinning depression |
| Q60445723 | Targeting the NLRP3 Inflammasome-Related Pathways via Tianeptine Treatment-Suppressed Microglia Polarization to the M1 Phenotype in Lipopolysaccharide-Stimulated Cultures |
| Q27004490 | Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date |
| Q38901677 | The Immune System and the Role of Inflammation in Perinatal Depression. |
| Q26783012 | The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific Treatments |
| Q35563633 | The Role of Nutrients in Protecting Mitochondrial Function and Neurotransmitter Signaling: Implications for the Treatment of Depression, PTSD, and Suicidal Behaviors. |
| Q92460762 | The antidepressant effects of GM-CSF are mediated by the reduction of TLR4/NF-ĸB-induced IDO expression |
| Q34343458 | The association of depression and anxiety with pain: a study from NESDA |
| Q99402135 | The complex interactions amongst serotonin, insulin, leptin and glycolipid metabolic parameters in human obesity |
| Q33887233 | The diagnosis of depression: current and emerging methods |
| Q42209744 | The effects of Nigella sativa hydro-alcoholic extract and thymoquinone on lipopolysaccharide - induced depression like behavior in rats |
| Q42754301 | The effects of Nigella sativa on sickness behavior induced by lipopolysaccharide in male Wistar rats |
| Q38711065 | The effects of Valeriana officinalis L. hydro-alcoholic extract on depression like behavior in ovalbumin sensitized rats. |
| Q38860400 | The effects of a probiotic formulation (Lactobacillus rhamnosus and L. helveticus) on developmental trajectories of emotional learning in stressed infant rats. |
| Q33715064 | The endogenous and reactive depression subtypes revisited: integrative animal and human studies implicate multiple distinct molecular mechanisms underlying major depressive disorder |
| Q36493625 | The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D). |
| Q34536698 | The impact of GPX1 on the association of groundwater selenium and depression: a Project FRONTIER study |
| Q38004705 | The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications |
| Q35945930 | The role of cytokines and hot flashes in perimenopausal depression |
| Q38103493 | The role of inflammatory cytokines on the aetiopathogenesis of depression |
| Q47560623 | The sinonasal microbiota, neural signaling, and depression in chronic rhinosinusitis |
| Q59137339 | The social defeat/overcrowding murine psychosocial stress model results in a pharmacologically reversible body weight gain but not depression - related behaviours |
| Q64944036 | Therapeutic Potential of Exogenous Ketone Supplement Induced Ketosis in the Treatment of Psychiatric Disorders: Review of Current Literature. |
| Q38454097 | Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research |
| Q42750430 | Traumatic stress, dissociation, and limbic irritability in patients with unipolar depression being treated with SSRIs |
| Q64066641 | Tryptophan Metabolic Pathways and Brain Serotonergic Activity: A Comparative Review |
| Q39181179 | Understanding the role of serotonin in psychiatric diseases |
| Q48039424 | Unpredictable Chronic Mild Stress Paradigm Established Effects of Pro- and Anti-inflammatory Cytokine on Neurodegeneration-Linked Depressive States in Hamsters with Brain Endothelial Damages. |
| Q48690651 | Urinary biopyrrins: potential biomarker for monitoring of the response to treatment with anxiolytics. |
| Q34590922 | Vascular pathology and blood-brain barrier disruption in cognitive and psychiatric complications of type 2 diabetes mellitus |
| Q42856763 | Venlafaxine inhibits apoptosis of hippocampal neurons by up-regulating brain-derived neurotrophic factor in a rat depression model. |
| Q49022902 | Vitamin D status in patients with MS is negatively correlated with depression, but not with fatigue |
| Q34233708 | Zinc and the ERK kinases in the developing brain. |
| Q37025484 | Zinc homeostasis and neurodegenerative disorders |
| Q44039584 | β-Amyloid induced effects on cholinergic, serotonergic, and dopaminergic neurons is differentially counteracted by anti-inflammatory drugs |
Search more.